THE INFLUENCE OF VARIOUS FACTORS ON BLOOD LOSS IN PATIENTS UNDERGOING TOTAL HIP REPLACEMENT

Cover Page

Abstract

Objective: to assess the influence of various factors on blood loss and blood parameters in the postoperative period in patients undergoing hip replacement surgery with and without tranexamic acid. Material and methods. The operations of primary and revision hip arthroplasty were performed in 646 patients with various pathology of the hip by two surgery teams. Patients were divided into two groups: with the use the tranexamic acid - 284 and without its application - 362. We determined the amount of intraoperative blood loss, blood parameters (hemoglobin, red blood cells, platelets) before surgery and in the first, third and sixth days after the operation. Also the analysis of drainage system influence is carried out. Results. The tranexamic acid application during total hip arthroplasty allows to reduce intraoperative blood loss, to optimize the process of normalization red blood in the postoperative period. The renunciation of wound drainage decreased the total amount of blood loss on average 2.2 times and respectively, the need for blood transfusions.

About the authors

R. M. Tikhilov

The Vreden’s Russian Research Institute of Traumatology and Orthopedics St.-Petersburg

Author for correspondence.
Email: info@rniito.org
Russian Federation

A. B. Serebryakov

Medical-Rehabilitation Center Moscow

Email: cvmr@bk.ru
Russian Federation

I. I. Shubnyakov

The Vreden’s Russian Research Institute of Traumatology and Orthopedics St.-Petersburg

Email: shubnyakov@mail.ru
Russian Federation

D. G. Pliev

The Vreden’s Russian Research Institute of Traumatology and Orthopedics St.-Petersburg

Email: plievd@gmail.com
Russian Federation

V. A. Shilnikov

The Vreden’s Russian Research Institute of Traumatology and Orthopedics St.-Petersburg

Email: vreden11@rambler.ru
Russian Federation

A. O. Denisov

The Vreden’s Russian Research Institute of Traumatology and Orthopedics St.-Petersburg

Email: med-03@yandex.ru
Russian Federation

A. A. Myasoedov

The Vreden’s Russian Research Institute of Traumatology and Orthopedics St.-Petersburg

Email: myasoedov_alexei@mail.ru
Russian Federation

A. A. Boyarov

The Vreden’s Russian Research Institute of Traumatology and Orthopedics St.-Petersburg

Email: bojaroffaa@mail.ru
Russian Federation

References

  1. Тихилов Р.М., Шубняков И.И., Моханна М.И., Плиев Д.Г., Мясоедов А.А., Цыбин А.В., Амбросенков А.В., Близнюков В.В., Чиладзе И.Т., Шулепов Д.А. Эффективность применения транексамовой кислоты для уменьшения кровопотери при эндопротезировании тазобедренного сустава. Вестник травматологии и ортопедии им. Н.Н. Приорова. 2010; (1):29-34.
  2. Шевченко Ю.Л., Стойко Ю.М., Замятин М.Н., Теплых Б.А., Карпов И.А., Смолькин Д.А. Кровесберегающий эффект транексамовой кислоты при протезировании коленного сустава. Общая реаниматология. 2008; (6):21-25.
  3. Amaranath L., Cascorbi H.F., Singh-Amaranath A.V., Frankmann D.B. Relation of anesthesia to total hip replacement and control of operative blood loss. Anesth. Analg. 1975;54:641-648.
  4. Blumberg N., Heal J.M., Murphy P., Agarwal M.M., Chuang C. Association between transfusion of whole blood and recurrence of cancer. British Med. J. 1986; 293:530-533.
  5. Blumberg N., Heal J.M. Evidence for plasma-mediated immunomodulation — transfusions of plasma-rich blood components are associated with a greater risk of acquired immunodeficiency syndrome than transfusions of red blood cells alone. Transplant. Proc. 1988; 20:1138-1142.
  6. Blumberg N., Heal J.M. Immunomodulation by blood transfusion: an evolving scientific and clinical challenge. Am. J. Med. 1996; 101:299-308.
  7. Brunson M.E., Alexander J.W. Mechanisms of transfusion-induced immunosuppression. Transfusion. 1990; 30:651-658.
  8. Chung W.K., Liu D. LSS Foo Mini-incision total hip replacement — surgical technique and early results. Journal of Orthopaedic Surgery. 2004;12(1):19 — 24.
  9. Cone J., Day L.J., Johnson G.K., Murray D.G., Nelson C.L. Blood products: optimal use, conservation, and safety. In: Instructional Course Lectures, American Academy of Orthopaedic Surgeons. Vol. 39. P. 431-434. Park Ridge, Illinois, American Academy of Orthopaedic Surgeons, 1990.
  10. Etchason J., Petz L., Keeler E., Calhoun L., Kleinman S., Snider C., Fink A., Brook R. The cost effectiveness of preoperative autologous blood donations. New England J. Med. 1995; 332:719-724.
  11. Forbes J.M., Anderson M.D., Anderson G.F., Bleecker G.C., Rossi E.C., Moss G.S. Blood transfusion costs: a multicenter study. Transfusion. 1991; 31:318-323.
  12. Goldman M., Remy-Prince S., Trepanier A., Decary F. Autologous donation error rates in Canada. Transfusion. 1997; 37:523-527.
  13. Guerra J.J., Cuckler J.M. Cost effectiveness of intraoperative autotransfusion in total hip arthroplasty surgery. Clin. Orthop. 1995; 315:212-222.
  14. Ido K., Neo M., Asada Y., Kondo K., Morita T., Sakamoto T., Hayashi R. Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties. Arch. Orthop. Trauma Surg. 2000;120(9):518-520.
  15. Lemaire R. Strategies for blood management in orthopaedic and trauma surgery. J. Bone Joint Surg. 2008; 90-B:1128-1136.
  16. Semkiw L.B., Schurman D.J., Goodman S.B., Woolson S.T. Postoperative blood salvage using the Cell Saver after total joint arthroplasty. J. Bone and Joint Surg. 1989; 71-A:823-827.
  17. Silvergleid A.J. Ed. Preoperative autologous donation: what have we learned? Transfusion. 1991; 31:99-101.
  18. Spence R.K., Sculco T.P., Keating E.M., Nelson C.L. Changing transfusion practices in orthopedic surgery. Orthopedics. 1995; 18:842-845.
  19. Thomson J.D., Callaghan J.J., Savory C.G., Stanton R.P., Pierce R.N. Prior deposition of autologous blood in elective orthopaedic surgery. J. Bone and Joint Surg. 1987; 69-A:320-324.
  20. Toy P.T., C. Y., Strauss R.G., Stehling L.C., Sears R., Price T.H., Rossi E.C., Collins M.L., Crowley J.P., Eisenstaedt R.S., Goodnough L.T., Greenwalt T.J., Johnston M.F.M., Kennedy M.S., Lenes B.A., Lusher J.M., Mintz P.D., Patten E.D., Simon T.L., Westphal R.G. Predeposited autologous blood for elective surgery. New England J. Med. 1987; 316:517-520.
  21. Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs. 1985; 29(3):236-261.
  22. Wilson W.J. Intraoperative autologous transfusion in revision total hip arthroplasty. J. Bone and Joint Surg. 1989; 71-A:8-14.
  23. Woolson S.T., Watt J.M. Use of autologous blood in total hip replacement. A comprehensive program. J. Bone Joint Surg. 1991;73-А:76-80.

Statistics

Views

Abstract: 377

Cited-by

CrossRef: 1

  1. Kochish AA, Bozhkova SA, Artyukh VA, Liventsov VN, Afanas’ev AV, Toropov SS. Improvement of Perioperative Management of Patients Undergoing Surgical Treatment for Hip Periprosthetic Joint Infection. Traumatology and Orthopedics of Russia. 2021;27(1):143. doi: 10.21823/2311-2905-2021-27-1-143-152

Dimensions

Article Metrics

Metrics Loading ...

PlumX


Copyright (c)



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies